Press releases & In the Press
-
French firms partner to provide pet cancer drug services
-
ImaBiotech boosts its strategic partnerships
-
Metabrain Research and ImaBiotech initiate a strategic partnership to offer cutting-edge preclinical research services in metabolic disorders.
-
OCR and ImaBiotech initiate a strategic partnership to provide in situ drug efficacy and target exposure services in Pets with naturally occurring tumors
-
Press: ImaBiotech poursuit son développement sur le Parc Eurasanté